Skip to content

Instantly share code, notes, and snippets.

@felipehummel

felipehummel/result.json

Created February 6, 2015 14:00
Show Gist options
  • Save felipehummel/b5371b32d356cb273e54 to your computer and use it in GitHub Desktop.
Save felipehummel/b5371b32d356cb273e54 to your computer and use it in GitHub Desktop.
Download ZIP
example json
Raw
result.json
{
"results":[{
"articles":[{
"id":147239368,
"created_at":"2015-02-06 13:49:11",
"type":"articles",
"title":"INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Hospira Inc. In Connection With the Fairness of the Sale of the Company to Pfizer -- HSP",
"language_code":"en",
"url":"http://www.benzinga.com/pressreleases/15/02/n5218605/investor-alert-levi-korsinsky-llp-commences-an-investigation-of-the-boa",
"published_at":"2015-02-06 13:41:48",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-06 13:41:48",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["us4410601003","benzinga","press releases","hsp"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49645,
"permalink":"press releases",
"name":"Press Releases"
}],
"author":"Newswire"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":41985,
"name":"board of directors",
"label":"Board Of Directors",
"score":0.0830504521727562
}],
"videos":[]
}],
"clusterId":147239371,
"clusterSize":4,
"score":18.356042861938477
},{
"articles":[{
"id":147228790,
"created_at":"2015-02-06 12:45:46",
"type":"articles",
"title":"Pfizer shares gain over 3% as parent plans to buy Hospira",
"language_code":"en",
"url":"http://economictimes.indiatimes.com/markets/stocks/news/pfizer-shares-gain-over-3-as-parent-plans-to-buy-hospira/articleshow/46145894.cms",
"published_at":"2015-02-06 12:22:29",
"directories":["Economia"],
"publishings":[{
"id":779,
"permalink":"the-economic-times",
"name":"The Economic Times",
"published_at":"2015-02-06 12:22:29",
"thumbnail":"TYEVCs1wx3hwoewNNXonKQUZcXEqA8MKEshyOYlW.png",
"categories":[],
"url":"http://economictimes.indiatimes.com/",
"feeds":[{
"id":65272,
"permalink":"the economic times",
"name":"The Economic Times"
},{
"id":65296,
"permalink":"stocks markets the economic times",
"name":"Stocks-Markets-The Economic Times"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":2,
"facebook_comments":0,
"facebook_total":2,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":51449,
"name":"datsun",
"label":"Datsun",
"score":0.10386703908443451
},{
"id":1173,
"name":"india",
"label":"India",
"score":0.08374371379613876
}],
"videos":[]
}],
"clusterId":147008276,
"clusterSize":260,
"score":2.9549834728240967
},{
"articles":[{
"id":147225803,
"created_at":"2015-02-06 12:24:14",
"type":"articles",
"title":"Global 2000: The Biggest Drug Companies Of 2014",
"language_code":"en",
"url":"http://www.forbes.com/pictures/fefi45mlid/no-1-pfizer-4/",
"published_at":"2015-02-06 12:18:00",
"directories":["Negócios","Economia"],
"publishings":[{
"id":10972,
"permalink":"forbes",
"name":"Forbes",
"published_at":"2015-02-06 12:18:00",
"thumbnail":"ts16aOJP0G2xq8inmYQ3rAWxV6PgJuIETAOEk9yX.png",
"categories":["nyse:hsp","nyse:abbv","nyse:ms","nyse:pfe","nasdaq:amgn"],
"url":"http://www.forbes.com/",
"feeds":[{
"id":24310,
"permalink":"forbes",
"name":"Forbes"
},{
"id":31826,
"permalink":"information for the worlds business leaders forbescom rss",
"name":"Information for the World's Business Leaders - Forbes.com - RSS"
}],
"author":"Bruce Japsen, Contributor"
}],
"images":[{
"url":"7bcd910c5cb168254ca036c52fae1ec8.jpg",
"width":620,
"height":434
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":3,
"facebook_comments":0,
"facebook_total":3,
"twitter":29,
"pinterest":0,
"linkedin":0,
"google_plusones":7
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.12892980873584747
},{
"id":120,
"name":"drugs",
"label":"Drugs",
"score":0.09622655063867569
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.08559897541999817
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.07900871336460114
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.06433847546577454
},{
"id":40969,
"name":"dva",
"label":"DVA",
"score":0.06331813335418701
},{
"id":26602,
"name":"prescription drugs",
"label":"Prescription Drugs",
"score":0.06155462563037872
},{
"id":27908,
"name":"bribery",
"label":"Bribery",
"score":0.06118260696530342
},{
"id":14964,
"name":"pharma",
"label":"Pharma",
"score":0.056171223521232605
},{
"id":8271,
"name":"bristol-myers squibb",
"label":"Bristol-myers Squibb",
"score":0.05594636872410774
}],
"videos":[]
}],
"clusterId":147225803,
"clusterSize":1,
"score":0.36117619276046753
},{
"articles":[{
"id":147176078,
"created_at":"2015-02-06 04:30:30",
"type":"articles",
"title":"Wall Street climbs with energy rebound, Pfizer deal",
"language_code":"en",
"url":"http://www.thehindubusinessline.com/markets/wall-street-climbs-with-energy-rebound-pfizer-deal/article6864369.ece",
"published_at":"2015-02-06 04:21:28",
"directories":["Internacional"],
"publishings":[{
"id":16173,
"permalink":"the-hindu-business-line",
"name":"The Hindu Business Line",
"published_at":"2015-02-06 04:21:28",
"thumbnail":"94186ab8317bb7b97600.png",
"categories":["markets"],
"url":"http://www.thehindubusinessline.com/",
"feeds":[{
"id":63845,
"permalink":"businessline home",
"name":"BusinessLine - Home"
},{
"id":63864,
"permalink":"businessline stocks",
"name":"BusinessLine - Stocks"
},{
"id":63865,
"permalink":"businessline markets",
"name":"BusinessLine - Markets"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":1,
"twitter":2,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.09367618709802628
},{
"id":5089,
"name":"dow jones",
"label":"Dow Jones",
"score":0.09195974469184875
},{
"id":24916,
"name":"wall",
"label":"Wall",
"score":0.08244005590677261
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.07380328327417374
},{
"id":10186,
"name":"nasdaq",
"label":"Nasdaq",
"score":0.06260722130537033
},{
"id":5097,
"name":"dow jones industrial average",
"label":"Dow Jones Industrial Average",
"score":0.05436590313911438
}],
"videos":[]
}],
"clusterId":147015685,
"clusterSize":79,
"score":0.30981823801994324
},{
"articles":[{
"id":147175761,
"created_at":"2015-02-06 04:26:59",
"type":"articles",
"title":"Pfizer rallies over 6% on acquisition plans; scales above Rs 2000",
"language_code":"en",
"url":"http://economictimes.indiatimes.com/markets/stocks/news/pfizer-rallies-over-6-on-acquisition-plans-scales-above-rs-2000/articleshow/46140486.cms",
"published_at":"2015-02-06 04:15:16",
"directories":["Economia"],
"publishings":[{
"id":779,
"permalink":"the-economic-times",
"name":"The Economic Times",
"published_at":"2015-02-06 04:15:16",
"thumbnail":"TYEVCs1wx3hwoewNNXonKQUZcXEqA8MKEshyOYlW.png",
"categories":[],
"url":"http://economictimes.indiatimes.com/",
"feeds":[{
"id":65296,
"permalink":"stocks markets the economic times",
"name":"Stocks-Markets-The Economic Times"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":2,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":3,
"twitter":14,
"pinterest":0,
"linkedin":3,
"google_plusones":0
},
"topics":[{
"id":13723,
"name":"financial markets",
"label":"Financial Markets",
"score":0.18781474232673645
},{
"id":13868,
"name":"delhi",
"label":"Delhi",
"score":0.09805865585803986
},{
"id":2617,
"name":"new delhi",
"label":"New Delhi",
"score":0.07195105403661728
},{
"id":1173,
"name":"india",
"label":"India",
"score":0.05816621705889702
}],
"videos":[]
}],
"clusterId":147175761,
"clusterSize":1,
"score":0.30561867356300354
},{
"articles":[{
"id":147236539,
"created_at":"2015-02-06 13:27:10",
"type":"articles",
"title":"Stock futures hold steady; RadioShack files for bankruptcy; Siemens cutting 7,800 jobs globally: A.M. Business News Links",
"language_code":"en",
"url":"http://www.cleveland.com/business/index.ssf/2015/02/stock_futures_hold_steady_radi.html",
"published_at":"2015-02-06 13:20:06",
"directories":["Cotidiano"],
"publishings":[{
"id":10567,
"permalink":"cleveland-plain-dealer",
"name":"Cleveland Plain Dealer",
"published_at":"2015-02-06 13:20:06",
"thumbnail":"jEr519wDOkK48wEIylBg0jB5f8AkjhWp1r5FV4qw.png",
"categories":["cat:business","tag:india-solar-power","cat:retail","tag:stock-futures","cat:workforce and workplace","tag:crude-oil-prices","cat:real-time news","cat:world news","tag:radioshack-bankruptcy","cat:economy","tag:siemens-job-cuts","tag:gopro-revenue","cat:link roundup","cat:technology","cat:nation","tag:asian-stocks","tag:irs-rehires-employees","tag:swatch-smartwatch"],
"url":"http://www.cleveland.com/",
"feeds":[{
"id":20661,
"permalink":"cleveland-plain-dealer",
"name":"Cleveland Plain Dealer"
},{
"id":38742,
"permalink":"business",
"name":"Business"
},{
"id":38747,
"permalink":"national news",
"name":"National News"
},{
"id":38767,
"permalink":"business technology",
"name":"Business: Technology"
}],
"author":"Ray Jablonski, Northeast Ohio Media Group"
}],
"images":[{
"url":"66388a8d2dd52b482324796cc97ef6eb.jpg",
"width":2048,
"height":1412
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":4,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":39168,
"name":"radioshack",
"label":"Radioshack",
"score":0.1570979803800583
},{
"id":20203,
"name":"siemens",
"label":"Siemens",
"score":0.11068322509527206
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.07452517002820969
},{
"id":43056,
"name":"alcatel",
"label":"Alcatel",
"score":0.07447086274623871
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.0717707946896553
},{
"id":26875,
"name":"stock",
"label":"Stock",
"score":0.07098942995071411
},{
"id":13734,
"name":"stock market",
"label":"Stock Market",
"score":0.06936796754598618
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.06520956009626389
},{
"id":65859,
"name":"do",
"label":"DO",
"score":0.05720239132642746
},{
"id":48417,
"name":"trade-in",
"label":"Trade-in",
"score":0.05504980310797691
}],
"videos":[]
}],
"clusterId":147196162,
"clusterSize":62,
"score":0.2946719229221344
},{
"articles":[{
"id":147168215,
"created_at":"2015-02-06 02:56:41",
"type":"articles",
"title":"Pfizer Bets $15 Billion On New Sort of Generics",
"language_code":"en",
"url":"http://www.thespec.com/news-story/5325803-pfizer-bets-15-billion-on-new-sort-of-generics/",
"published_at":"2015-02-06 02:44:45",
"directories":["Internacional"],
"publishings":[{
"id":16042,
"permalink":"the-hamilton-spectator",
"name":"The Hamilton Spectator",
"published_at":"2015-02-06 02:44:45",
"thumbnail":"88a9053a4f8e2cd406dc.png",
"categories":["news","news/world"],
"url":"http://www.thespec.com/hamilton/",
"feeds":[{
"id":61960,
"permalink":"hamilton news from http wwwthespeccom",
"name":"Hamilton-News (from http://www.thespec.com)"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.3531131148338318
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.2569617033004761
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.23373399674892426
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.17312124371528625
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.15573686361312866
},{
"id":5817,
"name":"novartis",
"label":"Novartis",
"score":0.14111535251140594
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.12426284700632095
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.10545315593481064
},{
"id":46324,
"name":"abbv",
"label":"Abbv",
"score":0.09623594582080841
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.09441035240888596
}],
"videos":[]
}],
"clusterId":147127072,
"clusterSize":5,
"score":0.2542394995689392
},{
"articles":[{
"id":147166658,
"created_at":"2015-02-06 02:37:32",
"type":"articles",
"title":"Breakingviews: Pfizer booster shot",
"language_code":"en",
"url":"http://in.reuters.com/video/2015/02/05/breakingviews-pfizer-booster-shot?videoId=363105579&videoChannel=104&channelName=Business",
"published_at":"2015-02-06 02:37:32",
"directories":[null],
"publishings":[{
"id":16927,
"permalink":"reuters-india",
"name":"Reuters India",
"published_at":"2015-02-06 02:37:32",
"thumbnail":"e15a0363bdce9a3c5994.png",
"categories":[],
"url":"http://in.reuters.com",
"feeds":[{
"id":85878,
"permalink":null,
"name":null
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.086485855281353
},{
"id":14964,
"name":"pharma",
"label":"Pharma",
"score":0.06694240868091583
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.05700666084885597
}],
"videos":[]
}],
"clusterId":147094894,
"clusterSize":3,
"score":0.25081074237823486
},{
"articles":[{
"id":147234903,
"created_at":"2015-02-06 13:17:25",
"type":"articles",
"title":"Fresh Deals on W-Street: Special Research on Hospira, BT Group, Actavis, Ball, and Frontier",
"language_code":"en",
"url":"http://www.prnewswire.com/news-releases/fresh-deals-on-w-street-special-research-on-hospira-bt-group-actavis-ball-and-frontier-291036921.html",
"published_at":"2015-02-06 13:10:00",
"directories":["Veículos","Press Releases"],
"publishings":[{
"id":10940,
"permalink":"pr-newswire-us",
"name":"PR Newswire US",
"published_at":"2015-02-06 13:10:00",
"thumbnail":"QKtalhNjD8PW4LRZ5mAfCnplI5GOblqOPRKlz3Kl.png",
"categories":[],
"url":"http://www.prnewswire.com/",
"feeds":[{
"id":24202,
"permalink":"pr-newswire-news-for-investors",
"name":"PR Newswire: News for Investors"
},{
"id":67298,
"permalink":"pr newswire",
"name":"PR Newswire:"
},{
"id":67299,
"permalink":"pr newswire",
"name":"PR Newswire:"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":32353,
"name":"act",
"label":"ACT",
"score":0.16883397102355957
},{
"id":4483,
"name":"bt",
"label":"BT",
"score":0.15443359315395355
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.10302206128835678
},{
"id":527,
"name":"http",
"label":"Http",
"score":0.08643445372581482
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.07687751948833466
},{
"id":55695,
"name":"bts",
"label":"BTS",
"score":0.0620880164206028
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.06165100261569023
},{
"id":50828,
"name":"rex",
"label":"REX",
"score":0.05814601108431816
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.054799921810626984
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.05118304118514061
}],
"videos":[]
}],
"clusterId":147234903,
"clusterSize":1,
"score":0.22855521738529205
},{
"articles":[{
"id":147234743,
"created_at":"2015-02-06 13:16:43",
"type":"articles",
"title":"America Is Ready for Currency Wars",
"language_code":"en",
"url":"http://www.bloombergview.com/articles/2015-02-06/america-is-ready-for-currency-wars",
"published_at":"2015-02-06 13:01:57",
"directories":["Negócios"],
"publishings":[{
"id":11837,
"permalink":"bloomberg-news",
"name":"Bloomberg News",
"published_at":"2015-02-06 13:01:57",
"thumbnail":"LoYrN6o365mFPBWSzLogy9eeYq3RwtkLAEOk0dx1.png",
"categories":["currency"],
"url":"http://www.bloomberg.com/",
"feeds":[{
"id":41034,
"permalink":"bview",
"name":"View"
}],
"author":"Mark Gilbert"
}],
"images":[{
"url":"f69784437d96092df2f7c325e1244c7a.jpg",
"width":557,
"height":540
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":3,
"facebook_comments":0,
"facebook_total":3,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14666,
"name":"dollar",
"label":"Dollar",
"score":0.1619029939174652
},{
"id":11630,
"name":"currencies",
"label":"Currencies",
"score":0.13216212391853333
},{
"id":24557,
"name":"exports",
"label":"Exports",
"score":0.12709642946720123
},{
"id":57036,
"name":"procter & gamble",
"label":"Procter & Gamble",
"score":0.09028434008359909
},{
"id":2248,
"name":"treasury",
"label":"Treasury",
"score":0.086613230407238
},{
"id":2258,
"name":"us treasury",
"label":"Us Treasury",
"score":0.0835113674402237
},{
"id":10212,
"name":"profit",
"label":"Profit",
"score":0.07590674608945847
},{
"id":2749,
"name":"fed",
"label":"FED",
"score":0.07515604794025421
},{
"id":57847,
"name":"jack lew",
"label":"Jack Lew",
"score":0.07278822362422943
},{
"id":815,
"name":"deficit",
"label":"Deficit",
"score":0.06733226776123047
}],
"videos":[]
}],
"clusterId":147234743,
"clusterSize":1,
"score":0.1937856823205948
},{
"articles":[{
"id":147149222,
"created_at":"2015-02-05 23:47:57",
"type":"articles",
"title":"Pfizer Xeljanz Label Expansion Application Under FDA Review - Analyst Blog",
"language_code":"en",
"url":"http://www.zacks.com/stock/news/163340/pfizer-xeljanz-label-expansion-application-under-fda-review",
"published_at":"2015-02-05 23:13:00",
"directories":["Negócios"],
"publishings":[{
"id":13871,
"permalink":"zacks-investment-research",
"name":"Zacks Investment Research",
"published_at":"2015-02-05 23:13:00",
"thumbnail":"6b9e038cc13b98bbaf68.png",
"categories":["analyst blog","nvs","ipxl","pfe","agn"],
"url":"http://www.zacks.com/",
"feeds":[{
"id":49641,
"permalink":"all",
"name":"all"
}],
"author":"Zacks Equity Research"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":9,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.4025737941265106
},{
"id":8626,
"name":"arthritis",
"label":"Arthritis",
"score":0.22557315230369568
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.21240700781345367
},{
"id":17357,
"name":"agn",
"label":"AGN",
"score":0.1463909149169922
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.12688642740249634
},{
"id":525,
"name":"mrk",
"label":"MRK",
"score":0.0914740338921547
},{
"id":908,
"name":"jnj",
"label":"JNJ",
"score":0.08662112802267075
},{
"id":23275,
"name":"abt",
"label":"ABT",
"score":0.0826861634850502
},{
"id":5817,
"name":"novartis",
"label":"Novartis",
"score":0.07657316327095032
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.06307755410671234
}],
"videos":[]
}],
"clusterId":147149222,
"clusterSize":1,
"score":0.179606094956398
},{
"articles":[{
"id":147106439,
"created_at":"2015-02-05 19:17:12",
"type":"articles",
"title":"Pfizer Deal and Other Mergers Show a Case of the Mondays, on a Thursday",
"language_code":"en",
"url":"http://dealbook.nytimes.com/2015/02/05/pfizer-deal-and-other-mergers-show-a-case-of-the-mondays-on-a-thursday/?_r=5",
"published_at":"2015-02-05 19:12:34",
"directories":["Cotidiano"],
"publishings":[{
"id":32,
"permalink":"the-new-york-times",
"name":"The New York Times",
"published_at":"2015-02-05 19:12:34",
"thumbnail":"IhSX8RM6FGxWgjOFk1RzQULet5bolgfA18KYH8Ay.png",
"categories":["ball corporation|bll|nyse","investment banking","healthcare"," acquisitions and divestitures","hospira inc","mergers & acquisitions","non-cyclical consumer goods","thomson reuters corporation|tri|nyse","pfizer inc|pfe|nyse","telecommunications","thomson reuters corporation","bt group plc|bt|nyse","ball corporation","pfizer inc","hospira inc|hsp|nyse","bt group plc","mergers","top headline 1"],
"url":"http://www.nytimes.com/",
"feeds":[{
"id":31442,
"permalink":"dealbook",
"name":"DealBook"
},{
"id":31498,
"permalink":"nyt most recent headlines",
"name":"NYT > Most Recent Headlines"
},{
"id":46449,
"permalink":"nyt most recent headlines",
"name":"NYT > Most Recent Headlines"
},{
"id":46452,
"permalink":"dealbook",
"name":"DealBook"
}],
"author":"By WILLIAM ALDEN"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":65,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":50686,
"name":"search and seizure",
"label":"Search And Seizure",
"score":0.12373392283916473
},{
"id":25009,
"name":"nuclear tests",
"label":"Nuclear Tests",
"score":0.10594043880701065
},{
"id":20282,
"name":"e-learning",
"label":"E-learning",
"score":0.10134650021791458
},{
"id":16107,
"name":"accounts",
"label":"Accounts",
"score":0.09196027368307114
},{
"id":54037,
"name":"the show",
"label":"The Show",
"score":0.08980021625757217
},{
"id":12881,
"name":"park geun-hye",
"label":"Park Geun-hye",
"score":0.08849597722291946
},{
"id":43069,
"name":"nelson",
"label":"Nelson",
"score":0.08408296853303909
},{
"id":26272,
"name":"targeted killings",
"label":"Targeted Killings",
"score":0.08208803087472916
},{
"id":41763,
"name":"terms of service",
"label":"Terms Of Service",
"score":0.07902941852807999
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.07466801255941391
}],
"videos":[]
}],
"clusterId":147009933,
"clusterSize":2,
"score":0.13254457712173462
},{
"articles":[{
"id":147104003,
"created_at":"2015-02-05 19:06:32",
"type":"articles",
"title":"Pfizer Runs Into Some Resistance",
"language_code":"en",
"url":"http://www.benzinga.com/general/movers-shakers/15/02/5215814/pfizer-runs-into-some-resistance",
"published_at":"2015-02-05 19:00:25",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-05 19:00:25",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["benzinga","intraday update","us4410601003","technicals","pfe","movers","us7170811035","trading ideas","hsp"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49642,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
},{
"id":49668,
"permalink":"intraday update",
"name":"Intraday Update"
},{
"id":49673,
"permalink":"technicals",
"name":"Technicals"
},{
"id":49690,
"permalink":"trading ideas",
"name":"Trading Ideas"
},{
"id":49703,
"permalink":"movers",
"name":"Movers"
},{
"id":49712,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
}],
"author":"Joel Elconin"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":3,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.12568815052509308
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.0821424126625061
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.05147506669163704
}],
"videos":[]
}],
"clusterId":147104003,
"clusterSize":1,
"score":0.13076245784759521
},{
"articles":[{
"id":147103389,
"created_at":"2015-02-05 19:03:42",
"type":"articles",
"title":"Pfizer and AstraZeneca in fresh acquisition deals",
"language_code":"en",
"url":"http://www.theguardian.com/business/2015/feb/05/pfizer-astrazeneca-financial-performance-us-viagra-hospira-actavis",
"published_at":"2014-12-16 14:13:53",
"directories":["Negócios","Cotidiano"],
"publishings":[{
"id":322,
"permalink":"the-guardian",
"name":"The Guardian",
"published_at":"2014-12-16 14:13:53",
"thumbnail":"Q5fMbczQMhUXtR97uGLhJ0Lr6Ui3vp36etpCNoBT.png",
"categories":["canadá","uk news","américas","us news","world news","pfizer","pharmaceuticals industry","business","astrazeneca"],
"url":"http://guardian.co.uk/",
"feeds":[{
"id":5161,
"permalink":"the-guardian-business",
"name":"The Guardian Business"
},{
"id":5166,
"permalink":"the-guardian-world",
"name":"The Guardian World"
}],
"author":"Sean Farrell"
}],
"images":[{
"url":"1d1b08de942ba98c20563108443a81ca.jpg",
"width":460,
"height":276
}],
"social_metrics":{
"facebook_likes":6,
"facebook_shares":2,
"facebook_comments":0,
"facebook_total":8,
"twitter":15,
"pinterest":0,
"linkedin":1,
"google_plusones":1
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.2065075784921646
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.19227316975593567
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.16868597269058228
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.11837923526763916
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.08271536976099014
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.06870361417531967
},{
"id":32353,
"name":"act",
"label":"ACT",
"score":0.062216609716415405
},{
"id":26602,
"name":"prescription drugs",
"label":"Prescription Drugs",
"score":0.054317209869623184
}],
"videos":[]
}],
"clusterId":147052672,
"clusterSize":2,
"score":0.13072383403778076
},{
"articles":[{
"id":147104066,
"created_at":"2015-02-05 19:06:56",
"type":"articles",
"title":"Pfizer: only in America",
"language_code":"en",
"url":"http://www.ft.com/cms/s/3/0d650b5a-ad58-11e4-97c1-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_us%2Ffeed%2F%2Fproduct",
"published_at":"2015-02-05 18:18:38",
"directories":["Economia"],
"publishings":[{
"id":321,
"permalink":"financial-times",
"name":"Financial Times",
"published_at":"2015-02-05 18:18:38",
"thumbnail":"71YPkpFEf8atVy5ko3cSAE2gg3O9BLvHqQ2UC0ax.png",
"categories":[],
"url":"http://www.ft.com/",
"feeds":[{
"id":32625,
"permalink":"ftcom us canadian companies",
"name":"FT.com - US & Canadian companies"
}]
}],
"images":[{
"url":"6dd3823387080d455d93715f0b0a8746.jpg",
"width":600,
"height":338
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.2224276065826416
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.18581506609916687
},{
"id":14964,
"name":"pharma",
"label":"Pharma",
"score":0.1171516552567482
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.0974944606423378
},{
"id":517,
"name":"sanofi",
"label":"Sanofi",
"score":0.08674180507659912
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.07112311571836472
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.0692439004778862
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.06308769434690475
},{
"id":10845,
"name":"eli lilly",
"label":"Eli Lilly",
"score":0.05984077975153923
},{
"id":19957,
"name":"financing",
"label":"Financing",
"score":0.05584965646266937
}],
"videos":[]
}],
"clusterId":147098255,
"clusterSize":4,
"score":0.12495271116495132
},{
"articles":[{
"id":147082157,
"created_at":"2015-02-05 17:15:31",
"type":"articles",
"title":"A Pfizer exec explains why it\u2019s so expensive to invent new drugs",
"language_code":"en",
"url":"http://qz.com/337684/a-pfizer-exec-explains-why-its-so-expensive-to-invent-new-drugs/",
"published_at":"2015-02-05 17:11:42",
"directories":["Negócios"],
"publishings":[{
"id":14127,
"permalink":"quartz",
"name":"Quartz",
"published_at":"2015-02-05 17:11:42",
"thumbnail":"e7bc223d3828711138ad.png",
"categories":["drugs","economics","pharmaceuticals","apple","tech","innovation","technology","science","creativity","google","uncategorized","pfizer","improvement","amazon","business","health","ideas"],
"url":"http://qz.com",
"feeds":[{
"id":51440,
"permalink":"quartz",
"name":"Quartz"
},{
"id":51441,
"permalink":"quartz",
"name":"Quartz"
}],
"author":"Sally Susman"
}],
"images":[{
"url":"030318b8fe8c33e8f8a377d8a8b58b93.jpg",
"width":640,
"height":360
}],
"social_metrics":{
"facebook_likes":15,
"facebook_shares":8,
"facebook_comments":0,
"facebook_total":23,
"twitter":28,
"pinterest":0,
"linkedin":657,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.16751404106616974
},{
"id":17439,
"name":"hepatitis c",
"label":"Hepatitis C",
"score":0.15152983367443085
},{
"id":8628,
"name":"treatment",
"label":"Treatment",
"score":0.1217016875743866
},{
"id":17435,
"name":"hepatitis",
"label":"Hepatitis",
"score":0.08864074945449829
},{
"id":8634,
"name":"patients",
"label":"Patients",
"score":0.08678250759840012
},{
"id":20063,
"name":"developing world",
"label":"Developing World",
"score":0.08337084949016571
},{
"id":47151,
"name":"costs",
"label":"Costs",
"score":0.08245525509119034
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.08074604719877243
},{
"id":3409,
"name":"aging",
"label":"Aging",
"score":0.07223279029130936
},{
"id":58561,
"name":"r&d",
"label":"R&D",
"score":0.07105559855699539
}],
"videos":[]
}],
"clusterId":147082157,
"clusterSize":1,
"score":0.1165667399764061
},{
"articles":[{
"id":147077272,
"created_at":"2015-02-05 16:53:53",
"type":"articles",
"title":"Jim Cramer Says Pfizer (PFE) Is Finally Doing Something Right",
"language_code":"en",
"url":"http://www.thestreet.com/video/13036645/jim-cramer-says-pfizer-pfe-is-finally-doing-something-right.html?cm_ven=RSSFeed&s=1",
"published_at":"2015-02-05 16:39:00",
"directories":["Negócios"],
"publishings":[{
"id":13873,
"permalink":"the-street",
"name":"The Street",
"published_at":"2015-02-05 16:39:00",
"thumbnail":"ff606b418a658420f68c.png",
"categories":["drugs","video: markets","biotech","market commentary","mergers and aquisitions","video: cramer","youtube","hsp"],
"url":"http://www.thestreet.com",
"feeds":[{
"id":49736,
"permalink":"biotech",
"name":"Biotech"
}],
"author":"[email protected] (Jim Cramer)"
}],
"images":[{
"url":"cb047aa0af226376afc1f28279066fc6.jpg",
"width":1120,
"height":630
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":3,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":24045,
"name":"mozilla firefox",
"label":"Mozilla Firefox",
"score":0.23295734822750092
},{
"id":12418,
"name":"google keep",
"label":"Google Keep",
"score":0.12428249418735504
},{
"id":26381,
"name":"here",
"label":"Here",
"score":0.11982086300849915
},{
"id":54906,
"name":"in brief",
"label":"In Brief",
"score":0.11807160079479218
},{
"id":13995,
"name":"mozilla",
"label":"Mozilla",
"score":0.11536569893360138
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.10790987312793732
},{
"id":24047,
"name":"safari",
"label":"Safari",
"score":0.10625170171260834
},{
"id":10833,
"name":"google chrome",
"label":"Google Chrome",
"score":0.10545848309993744
},{
"id":4133,
"name":"chrome",
"label":"Chrome",
"score":0.10287804901599884
},{
"id":13994,
"name":"firefox",
"label":"Firefox",
"score":0.09455067664384842
}],
"videos":[]
}],
"clusterId":147077272,
"clusterSize":2,
"score":0.11283230781555176
},{
"articles":[{
"id":147147283,
"created_at":"2015-02-05 23:32:58",
"type":"articles",
"title":"HOSPIRA INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Pfizer Inc.",
"language_code":"en",
"url":"http://www.bloomberg.com/article/2015-02-05/a4p01qDHxjNY.html",
"published_at":"2015-02-05 16:26:00",
"directories":[null],
"publishings":[{
"id":15203,
"permalink":"bloomberg-markets",
"name":"Bloomberg Markets",
"published_at":"2015-02-05 16:26:00",
"thumbnail":"0f818bb3c3e67b890472.png",
"categories":[],
"url":"http://www.bloomberg.com/markets-magazine/",
"feeds":[{
"id":65337,
"permalink":null,
"name":null
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":12449,
"name":"shareholders",
"label":"Shareholders",
"score":0.1621597409248352
},{
"id":17250,
"name":"litigation",
"label":"Litigation",
"score":0.10494185984134674
},{
"id":26138,
"name":"attorney",
"label":"Attorney",
"score":0.08307155221700668
},{
"id":19555,
"name":"sec",
"label":"SEC",
"score":0.056370995938777924
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.05427863448858261
}],
"videos":[]
}],
"clusterId":147075354,
"clusterSize":2,
"score":0.11140747368335724
},{
"articles":[{
"id":147081946,
"created_at":"2015-02-05 17:14:32",
"type":"articles",
"title":"Pfizer Leads the Dow Higher as Oil, Jobs Lift Optimism",
"language_code":"en",
"url":"http://www.foxbusiness.com/investing/2015/02/05/pfizer-leads-dow-higher-as-oil-jobs-lift-optimism/",
"published_at":"2015-02-05 15:59:15",
"directories":["Economia"],
"publishings":[{
"id":10763,
"permalink":"fox-business",
"name":"FOX Business",
"published_at":"2015-02-05 15:59:15",
"thumbnail":"b5678fef0ea3dfffbd6d.png",
"categories":[],
"url":"http://www.foxbusiness.com/",
"feeds":[{
"id":36056,
"permalink":"",
"name":"FOX business investing"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":5876,
"name":"dow",
"label":"DOW",
"score":0.21752089262008667
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.21117722988128662
},{
"id":13734,
"name":"stock market",
"label":"Stock Market",
"score":0.16221210360527039
},{
"id":5089,
"name":"dow jones",
"label":"Dow Jones",
"score":0.11674211919307709
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.11141664534807205
},{
"id":59062,
"name":"wednesday",
"label":"Wednesday",
"score":0.10526620596647263
},{
"id":64740,
"name":"close",
"label":"Close",
"score":0.0962613970041275
},{
"id":54964,
"name":"dan",
"label":"DAN",
"score":0.08195905387401581
},{
"id":41173,
"name":"lo",
"label":"LO",
"score":0.07756516337394714
},{
"id":4095,
"name":"markets",
"label":"Markets",
"score":0.07481111586093903
}],
"videos":[]
}],
"clusterId":147057572,
"clusterSize":3,
"score":0.10857617110013962
},{
"articles":[{
"id":147137614,
"created_at":"2015-02-05 22:25:00",
"type":"articles",
"title":"FDA concede aprovação antecipada para novo medicamento da Pfizer contra câncer de mama",
"language_code":"en",
"url":"http://www.portalimprensa.com.br/noticias/prnewswire/54075/fda+concede+aprovacao+antecipada+para+novo+medicamento+da+pfizer+contra+cancer+de+mama",
"published_at":"2015-02-05 15:55:00",
"directories":["Cotidiano"],
"publishings":[{
"id":15640,
"permalink":"portal-imprensa",
"name":"Portal IMPRENSA",
"published_at":"2015-02-05 15:55:00",
"thumbnail":"dc5bc75d8df4aed30397.png",
"categories":[],
"url":"http://portalimprensa.com.br/",
"feeds":[{
"id":58786,
"permalink":"",
"name":"SiteCrawler Feed"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.039125602692365646
}],
"videos":[]
}],
"clusterId":147137614,
"clusterSize":1,
"score":0.10813836008310318
},{
"articles":[{
"id":147231354,
"created_at":"2015-02-06 12:57:15",
"type":"articles",
"title":"Frontrunning: February 6",
"language_code":"en",
"url":"http://www.zerohedge.com/news/2015-02-06/frontrunning-february-6",
"published_at":"2015-02-06 12:40:19",
"directories":["Internacional"],
"publishings":[{
"id":16504,
"permalink":"newsphiles",
"name":"Newsphiles",
"published_at":"2015-02-06 12:40:19",
"thumbnail":null,
"categories":["wells fargo","keefe","standard chartered","securities and exchange commission","goldman sachs","opec","european central bank","twitter","morgan stanley","japan","news corp","insider trading","citigroup","barclays","reuters","keycorp","ukraine","recovery","b+","china","verizon","credit suisse","capstone","viacom","iran","consumer credit","trian","prudential","evercore","greece","yuan","bby","barack obama","regions financial","unemployment","florida","creditors","raymond james","corruption","bank of america","germany","best buy","brazil","general motors","merrill lynch","deutsche bank","merrill"],
"url":"http://www.newsphiles.org/",
"feeds":[{
"id":70196,
"permalink":"zero hedge",
"name":"Zero Hedge"
}],
"author":"Tyler Durden"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":3,
"facebook_comments":0,
"facebook_total":3,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":527,
"name":"http",
"label":"Http",
"score":0.06744587421417236
},{
"id":6022,
"name":"bank",
"label":"Bank",
"score":0.058672886341810226
},{
"id":25742,
"name":"citi",
"label":"Citi",
"score":0.05317474529147148
},{
"id":13723,
"name":"financial markets",
"label":"Financial Markets",
"score":0.05313192680478096
},{
"id":39168,
"name":"radioshack",
"label":"Radioshack",
"score":0.05117975175380707
}],
"videos":[]
}],
"clusterId":147231354,
"clusterSize":1,
"score":0.10730123519897461
},{
"articles":[{
"id":147062518,
"created_at":"2015-02-05 15:34:24",
"type":"articles",
"title":"Pfizer Flexes Muscle With Priciest Purchase of Decade",
"language_code":"en",
"url":"http://www.bloomberg.com/news/articles/2015-02-05/pfizer-flexes-muscle-with-priciest-purchase-of-decade-real-m-a",
"published_at":"2015-02-05 15:12:00",
"directories":[null],
"publishings":[{
"id":15203,
"permalink":"bloomberg-markets",
"name":"Bloomberg Markets",
"published_at":"2015-02-05 15:12:00",
"thumbnail":"0f818bb3c3e67b890472.png",
"categories":[],
"url":"http://www.bloomberg.com/markets-magazine/",
"feeds":[{
"id":65337,
"permalink":null,
"name":null
}]
}],
"images":[{
"url":"e82810a9bac818c386c3d49a76e71b68.jpg",
"width":2500,
"height":1667
}],
"social_metrics":{
"facebook_likes":47,
"facebook_shares":24,
"facebook_comments":21,
"facebook_total":92,
"twitter":59,
"pinterest":0,
"linkedin":44,
"google_plusones":1
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.2159990668296814
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.16308555006980896
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.11036916822195053
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.0874049961566925
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.07301830500364304
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.0703640952706337
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.06910198926925659
},{
"id":10845,
"name":"eli lilly",
"label":"Eli Lilly",
"score":0.06545946002006531
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.06496959924697876
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.06119949370622635
}],
"videos":[]
}],
"clusterId":147062518,
"clusterSize":1,
"score":0.10388285666704178
},{
"articles":[{
"id":147061902,
"created_at":"2015-02-05 15:30:30",
"type":"articles",
"title":"Why Pfizer wants Hospira",
"language_code":"en",
"url":"http://www.cnbc.com/id/102400727",
"published_at":"2015-02-05 15:04:00",
"directories":["Negócios","Cotidiano"],
"publishings":[{
"id":10748,
"permalink":"cnbc",
"name":"CNBC",
"published_at":"2015-02-05 15:04:00",
"thumbnail":"mp4b0fOxwztaekKOcmbSsBuF6M1dDtYnIiEq6K1a.png",
"categories":[],
"url":"http://cnbc.com/",
"feeds":[{
"id":22780,
"permalink":"cnbc",
"name":"CNBC"
},{
"id":30404,
"permalink":"top",
"name":"Top"
},{
"id":64583,
"permalink":"top news and analysis",
"name":"Top News and Analysis"
},{
"id":64585,
"permalink":"health care",
"name":"Health Care"
}]
}],
"images":[{
"url":"d12bc6f95fbefb7cfadf59135148a46c.jpg",
"width":530,
"height":298
}],
"social_metrics":{
"facebook_likes":1,
"facebook_shares":9,
"facebook_comments":1,
"facebook_total":11,
"twitter":37,
"pinterest":0,
"linkedin":8,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.09407065808773041
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.08395759016275406
},{
"id":17439,
"name":"hepatitis c",
"label":"Hepatitis C",
"score":0.07066584378480911
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.06654544174671173
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.05304505676031113
}],
"videos":[]
}],
"clusterId":147061902,
"clusterSize":1,
"score":0.10312458872795105
},{
"articles":[{
"id":147220761,
"created_at":"2015-02-06 11:52:56",
"type":"articles",
"title":"CNBC's Stock Pops & Drops From February 5",
"language_code":"en",
"url":"http://www.benzinga.com/media/cnbc/15/02/5217596/cnbcs-stock-pops-drops-from-february-5",
"published_at":"2015-02-06 11:44:46",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-06 11:44:46",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["dan nathan","guy adami","benzinga","cmi","media","karen finerman","us4627261005","us5024701071","us2310211063","pfe","irbt","lb","us7170811035","trading ideas","cnbc"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49642,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
},{
"id":49657,
"permalink":"media",
"name":"Media"
},{
"id":49664,
"permalink":"cnbc",
"name":"CNBC"
},{
"id":49690,
"permalink":"trading ideas",
"name":"Trading Ideas"
},{
"id":49712,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
}],
"author":"Craig Jones"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":12306,
"name":"cmi",
"label":"CMI",
"score":0.1008170023560524
},{
"id":2070,
"name":"irobot",
"label":"Irobot",
"score":0.088873490691185
},{
"id":4176,
"name":"lf",
"label":"LF",
"score":0.08171843737363815
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.07761438190937042
},{
"id":2827,
"name":"fl",
"label":"FL",
"score":0.06717570126056671
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.06462854146957397
},{
"id":34533,
"name":"aro",
"label":"ARO",
"score":0.06357188522815704
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.06269357353448868
},{
"id":30730,
"name":"trading",
"label":"Trading",
"score":0.05817408114671707
},{
"id":5426,
"name":"kors",
"label":"Kors",
"score":0.05346623435616493
}],
"videos":[]
}],
"clusterId":147220761,
"clusterSize":1,
"score":0.10145002603530884
},{
"articles":[{
"id":147051062,
"created_at":"2015-02-05 14:50:09",
"type":"articles",
"title":"Stocks rally on oil; Dow up triple digits on Pfizer",
"language_code":"en",
"url":"http://www.cnbc.com/id/102400381",
"published_at":"2015-02-05 14:38:28",
"directories":["Negócios","Cotidiano"],
"publishings":[{
"id":3734,
"permalink":"NBC-news",
"name":"NBC News",
"published_at":"2015-02-05 14:38:28",
"thumbnail":"b3c6a6e9cc238400bfef.png",
"categories":[],
"url":"http://www.nbcnews.com",
"feeds":[{
"id":32353,
"permalink":"breaking news wwwbreakingnewscom",
"name":"Breaking news - www.breakingnews.com"
}],
"author":"Tricia McDermott"
},{
"id":10748,
"permalink":"cnbc",
"name":"CNBC",
"published_at":"2015-02-05 15:12:00",
"thumbnail":"mp4b0fOxwztaekKOcmbSsBuF6M1dDtYnIiEq6K1a.png",
"categories":[],
"url":"http://cnbc.com/",
"feeds":[{
"id":64561,
"permalink":"power lunch",
"name":"Power Lunch"
},{
"id":64576,
"permalink":"us dollar",
"name":"U.S. Dollar"
},{
"id":64593,
"permalink":"markets headlines",
"name":"Markets Headlines"
}]
}],
"images":[{
"url":"5c08b7d2e93c115d3faa8864f4e401b1.jpg",
"width":530,
"height":298
}],
"social_metrics":{
"facebook_likes":9,
"facebook_shares":45,
"facebook_comments":4,
"facebook_total":58,
"twitter":242,
"pinterest":0,
"linkedin":8,
"google_plusones":1
},
"topics":[{
"id":5089,
"name":"dow jones",
"label":"Dow Jones",
"score":0.11756929755210876
},{
"id":5097,
"name":"dow jones industrial average",
"label":"Dow Jones Industrial Average",
"score":0.106045201420784
},{
"id":64740,
"name":"close",
"label":"Close",
"score":0.08197872340679169
},{
"id":17727,
"name":"cme",
"label":"CME",
"score":0.0760267972946167
},{
"id":30730,
"name":"trading",
"label":"Trading",
"score":0.07523713260889053
},{
"id":2749,
"name":"fed",
"label":"FED",
"score":0.06314386427402496
},{
"id":52381,
"name":"new york stock exchange",
"label":"New York Stock Exchange",
"score":0.06180908530950546
},{
"id":815,
"name":"deficit",
"label":"Deficit",
"score":0.05814995616674423
},{
"id":20220,
"name":"oil prices",
"label":"Oil Prices",
"score":0.05620195344090462
},{
"id":24916,
"name":"wall",
"label":"Wall",
"score":0.0541926808655262
}],
"videos":[]
}],
"clusterId":147051062,
"clusterSize":1,
"score":0.10077042132616043
},{
"articles":[{
"id":147061583,
"created_at":"2015-02-05 15:28:58",
"type":"articles",
"title":"Pfizer eyes growth in biosimilar injectable market",
"language_code":"en",
"url":"http://video.foxbusiness.com/v/4033976063001/pfizer-eyes-growth-in-biosimilar-injectable-market--/",
"published_at":"2015-02-05 14:28:36",
"directories":["Economia"],
"publishings":[{
"id":10763,
"permalink":"fox-business",
"name":"FOX Business",
"published_at":"2015-02-05 14:28:36",
"thumbnail":"b5678fef0ea3dfffbd6d.png",
"categories":["on_air/opening_bell","on_air","personality/maria_bartiromo","personality","industries/health_care","industries","settings/advertising/ad_supported"],
"url":"http://www.foxbusiness.com/",
"feeds":[{
"id":36063,
"permalink":"",
"name":"FOX business video"
}]
}],
"images":[{
"url":"62b11cb1c7d12311cd45e6acf16add31.jpg",
"width":640,
"height":360
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":2,
"pinterest":0,
"linkedin":1,
"google_plusones":0
},
"topics":[{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.07433159649372101
}],
"videos":[]
}],
"clusterId":147061583,
"clusterSize":1,
"score":0.09988673031330109
},{
"articles":[{
"id":147050645,
"created_at":"2015-02-05 14:48:53",
"type":"articles",
"title":"Morning Movers: Hospira Soars on Pfizer Takeout; Kors Crumbles on Guidance",
"language_code":"en",
"url":"http://blogs.barrons.com/stockstowatchtoday/2015/02/05/morning-movers-hospira-soars-on-pfizer-takeout-kors-crumbles-on-guidance/?mod=BOLBlog",
"published_at":"2015-02-05 14:09:50",
"directories":["Negócios"],
"publishings":[{
"id":13654,
"permalink":"barrons",
"name":"Barron's",
"published_at":"2015-02-05 14:09:50",
"thumbnail":"7af8c99c770b02be60a5.png",
"categories":["stocks"],
"url":"http://online.barrons.com/home-page",
"feeds":[{
"id":48726,
"permalink":"stocks to watch",
"name":"Stocks To Watch"
}],
"author":"Ben Levisohn"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":1,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":5089,
"name":"dow jones",
"label":"Dow Jones",
"score":0.14576606452465057
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.11901433020830154
},{
"id":5097,
"name":"dow jones industrial average",
"label":"Dow Jones Industrial Average",
"score":0.11832357197999954
},{
"id":5426,
"name":"kors",
"label":"Kors",
"score":0.1060616597533226
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.082365483045578
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.07154107093811035
},{
"id":13734,
"name":"stock market",
"label":"Stock Market",
"score":0.06876083463430405
},{
"id":4095,
"name":"markets",
"label":"Markets",
"score":0.06679414212703705
},{
"id":62490,
"name":"ltd",
"label":"LTD",
"score":0.06560885906219482
},{
"id":52381,
"name":"new york stock exchange",
"label":"New York Stock Exchange",
"score":0.061655208468437195
}],
"videos":[]
}],
"clusterId":147050645,
"clusterSize":1,
"score":0.09824427962303162
},{
"articles":[{
"id":147034827,
"created_at":"2015-02-05 14:06:32",
"type":"articles",
"title":"Pfizer snatches up Hospira in $15.2 billion cash deal",
"language_code":"en",
"url":"http://www.bizjournals.com/chicago/news/2015/02/05/pfizer-buys-up-hospira-in-15-2-billion-cash-deal.html",
"published_at":"2015-02-05 13:49:31",
"directories":["Saúde"],
"publishings":[{
"id":10759,
"permalink":"the-business-journals",
"name":"The Business Journals",
"published_at":"2015-02-05 13:49:31",
"thumbnail":"e803312d5d3e36698e6e.png",
"categories":[],
"url":"http://www.bizjournals.com",
"feeds":[{
"id":35470,
"permalink":"health care news health care news headlines bizjournalscom",
"name":"Health Care News - Health Care News Headlines \\| Bizjournals.com"
}]
}],
"images":[{
"url":"f667aff1fdcb231c80ff5375bf5bdfcd.jpg",
"width":304,
"height":203
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":1,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.15582573413848877
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.10390051454305649
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.09715471416711807
},{
"id":67161,
"name":"mas",
"label":"MAS",
"score":0.08112259209156036
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.06343530863523483
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.06004355847835541
},{
"id":23159,
"name":"pay",
"label":"PAY",
"score":0.057151444256305695
},{
"id":46324,
"name":"abbv",
"label":"Abbv",
"score":0.05565293878316879
},{
"id":29647,
"name":"eln",
"label":"ELN",
"score":0.05263971537351608
}],
"videos":[]
}],
"clusterId":147034828,
"clusterSize":2,
"score":0.09652075171470642
},{
"articles":[{
"id":147051641,
"created_at":"2015-02-05 14:51:50",
"type":"articles",
"title":"5 Things Pfizer, Inc.'s Management Wants You to Know",
"language_code":"en",
"url":"http://www.foxbusiness.com/investing/2015/02/05/5-things-pfizer-inc-management-wants-to-know/",
"published_at":"2015-02-05 13:03:01",
"directories":["Economia"],
"publishings":[{
"id":10763,
"permalink":"fox-business",
"name":"FOX Business",
"published_at":"2015-02-05 13:03:01",
"thumbnail":"b5678fef0ea3dfffbd6d.png",
"categories":[],
"url":"http://www.foxbusiness.com/",
"feeds":[{
"id":36056,
"permalink":"",
"name":"FOX business investing"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":2,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.3084684908390045
},{
"id":1936,
"name":"melanoma",
"label":"Melanoma",
"score":0.1616678535938263
},{
"id":12449,
"name":"shareholders",
"label":"Shareholders",
"score":0.15958675742149353
},{
"id":13126,
"name":"dividend",
"label":"Dividend",
"score":0.15761788189411163
},{
"id":8271,
"name":"bristol-myers squibb",
"label":"Bristol-myers Squibb",
"score":0.1413334757089615
},{
"id":1794,
"name":"cancer",
"label":"Cancer",
"score":0.13613136112689972
},{
"id":104,
"name":"oncology",
"label":"Oncology",
"score":0.11322670429944992
},{
"id":1933,
"name":"merck",
"label":"Merck",
"score":0.10774488747119904
},{
"id":21337,
"name":"skin cancer",
"label":"Skin Cancer",
"score":0.10149206966161728
},{
"id":1732,
"name":"ovarian cancer",
"label":"Ovarian Cancer",
"score":0.10063166171312332
}],
"videos":[]
}],
"clusterId":147019156,
"clusterSize":2,
"score":0.09277623146772385
},{
"articles":[{
"id":147018875,
"created_at":"2015-02-05 13:15:53",
"type":"articles",
"title":"#BREAKING $15B-plus buyout: Hospira up 36% premarket on news of Pfizer deal http://t.co/17iRmgWFcu - @USATODAY",
"language_code":"en",
"url":"https://twitter.com/USATODAY/status/563317451946205185",
"published_at":"2015-02-05 12:46:10",
"directories":["Cotidiano"],
"publishings":[{
"id":3734,
"permalink":"NBC-news",
"name":"NBC News",
"published_at":"2015-02-05 12:46:10",
"thumbnail":"b3c6a6e9cc238400bfef.png",
"categories":[],
"url":"http://www.nbcnews.com",
"feeds":[{
"id":32353,
"permalink":"breaking news wwwbreakingnewscom",
"name":"Breaking news - www.breakingnews.com"
}],
"author":"David Wyllie"
}],
"images":[{
"url":"aee27b711590eba06520708bfff20407.jpg",
"width":400,
"height":400
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":13,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.05988970771431923
}],
"videos":[]
}],
"clusterId":147018875,
"clusterSize":1,
"score":0.0914839580655098
},{
"articles":[{
"id":147011785,
"created_at":"2015-02-05 12:36:41",
"type":"articles",
"title":"BRIEF-AstraZeneca CEO says 55 stg/shr Pfizer offer would likely never have happened",
"language_code":"en",
"url":"http://in.reuters.com/article/2015/02/05/astrazeneca-results-idINWLA008FM20150205?type=companyNews",
"published_at":"2015-02-05 12:36:41",
"directories":[null],
"publishings":[{
"id":16927,
"permalink":"reuters-india",
"name":"Reuters India",
"published_at":"2015-02-05 12:36:41",
"thumbnail":"e15a0363bdce9a3c5994.png",
"categories":[],
"url":"http://in.reuters.com",
"feeds":[{
"id":85878,
"permalink":null,
"name":null
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.2820025384426117
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.14572355151176453
},{
"id":16655,
"name":"roche",
"label":"Roche",
"score":0.0693589448928833
},{
"id":8639,
"name":"genentech",
"label":"Genentech",
"score":0.06408584117889404
},{
"id":3889,
"name":"azn",
"label":"AZN",
"score":0.062203940004110336
},{
"id":10877,
"name":"bayer",
"label":"Bayer",
"score":0.05748089775443077
},{
"id":23086,
"name":"biotech",
"label":"Biotech",
"score":0.05583469197154045
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.054807860404253006
},{
"id":10845,
"name":"eli lilly",
"label":"Eli Lilly",
"score":0.053135741502046585
},{
"id":8271,
"name":"bristol-myers squibb",
"label":"Bristol-myers Squibb",
"score":0.05179624632000923
}],
"videos":[]
}],
"clusterId":146994585,
"clusterSize":5,
"score":0.09077098220586777
},{
"articles":[{
"id":147013194,
"created_at":"2015-02-05 12:44:15",
"type":"articles",
"title":"DealBook: Pfizer to Buy Hospira, a Drug Maker, for $15.2 Billion in Cash",
"language_code":"en",
"url":"http://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash/?partner=rss&emc=rss&_r=5",
"published_at":"2015-02-05 12:30:18",
"directories":["Cotidiano"],
"publishings":[{
"id":32,
"permalink":"the-new-york-times",
"name":"The New York Times",
"published_at":"2015-02-05 12:30:18",
"thumbnail":"IhSX8RM6FGxWgjOFk1RzQULet5bolgfA18KYH8Ay.png",
"categories":["healthcare"," acquisitions and divestitures","hospira inc","mergers & acquisitions","pfizer inc|pfe|nyse","drugs (pharmaceuticals)","pfizer inc","hospira inc|hsp|nyse","mergers","top headline 1"],
"url":"http://www.nytimes.com/",
"feeds":[{
"id":20537,
"permalink":"the-new-york-times",
"name":"The New York Times"
},{
"id":31433,
"permalink":"nyt business day",
"name":"NYT > Business Day"
},{
"id":31437,
"permalink":"nyt business",
"name":"NYT > Business"
},{
"id":31496,
"permalink":"nyt most viewed",
"name":"NYT > Most Viewed"
},{
"id":46441,
"permalink":"nyt home page",
"name":"NYT > Home Page"
},{
"id":46450,
"permalink":"nyt business day",
"name":"NYT > Business Day"
},{
"id":46459,
"permalink":"nyt most viewed",
"name":"NYT > Most Viewed"
}],
"author":"By DAVID GELLES"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":784,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":50686,
"name":"search and seizure",
"label":"Search And Seizure",
"score":0.09602285176515579
},{
"id":20282,
"name":"e-learning",
"label":"E-learning",
"score":0.07960741221904755
},{
"id":25009,
"name":"nuclear tests",
"label":"Nuclear Tests",
"score":0.0788363665342331
},{
"id":41231,
"name":"google inc",
"label":"Google Inc",
"score":0.0778575986623764
},{
"id":12881,
"name":"park geun-hye",
"label":"Park Geun-hye",
"score":0.06585493683815002
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.06542392820119858
},{
"id":41763,
"name":"terms of service",
"label":"Terms Of Service",
"score":0.0630597397685051
},{
"id":16107,
"name":"accounts",
"label":"Accounts",
"score":0.0628010705113411
},{
"id":43069,
"name":"nelson",
"label":"Nelson",
"score":0.0625709667801857
},{
"id":26272,
"name":"targeted killings",
"label":"Targeted Killings",
"score":0.061086419969797134
}],
"videos":[]
}],
"clusterId":146909876,
"clusterSize":15,
"score":0.09029673784971237
},{
"articles":[{
"id":147007978,
"created_at":"2015-02-05 12:16:31",
"type":"articles",
"title":"Pharmaceutical giant Pfizer to buy Hospira in deal worth $17 billion - @Street_Insider",
"language_code":"en",
"url":"http://www.streetinsider.com/Press+Releases/Pfizer+To+Acquire+Hospira/10230979.html",
"published_at":"2015-02-05 12:11:18",
"directories":["Cotidiano"],
"publishings":[{
"id":3734,
"permalink":"NBC-news",
"name":"NBC News",
"published_at":"2015-02-05 12:11:18",
"thumbnail":"b3c6a6e9cc238400bfef.png",
"categories":[],
"url":"http://www.nbcnews.com",
"feeds":[{
"id":32353,
"permalink":"breaking news wwwbreakingnewscom",
"name":"Breaking news - www.breakingnews.com"
}],
"author":"David Wyllie"
}],
"images":[],
"social_metrics":{
"facebook_likes":2,
"facebook_shares":11,
"facebook_comments":1,
"facebook_total":14,
"twitter":113,
"pinterest":0,
"linkedin":0,
"google_plusones":1
},
"topics":[{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.25344333052635193
},{
"id":12449,
"name":"shareholders",
"label":"Shareholders",
"score":0.1392282396554947
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.13692784309387207
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.13148440420627594
},{
"id":12151,
"name":"m&a",
"label":"M&A",
"score":0.08396188169717789
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.08126678317785263
},{
"id":19555,
"name":"sec",
"label":"SEC",
"score":0.08101411908864975
},{
"id":3633,
"name":"acquisitions",
"label":"Acquisitions",
"score":0.08038445562124252
},{
"id":31153,
"name":"proxy",
"label":"Proxy",
"score":0.07588181644678116
},{
"id":19957,
"name":"financing",
"label":"Financing",
"score":0.07574044913053513
}],
"videos":[]
}],
"clusterId":147007978,
"clusterSize":1,
"score":0.0889115035533905
},{
"articles":[{
"id":147225112,
"created_at":"2015-02-06 12:19:55",
"type":"articles",
"title":"Futures Unchanged Ahead Of Payrolls",
"language_code":"en",
"url":"http://www.zerohedge.com/news/2015-02-06/futures-unchanged-ahead-payrolls",
"published_at":"2015-02-06 11:52:29",
"directories":["Internacional"],
"publishings":[{
"id":16504,
"permalink":"newsphiles",
"name":"Newsphiles",
"published_at":"2015-02-06 11:52:29",
"thumbnail":null,
"categories":["crude oil","none","cboe","twitter","france","japan","headlines","reality","fixed","ransquawk","vladimir putin","reuters","ukraine","china","eurozone","nikkei","crude","price action","consumer credit","greece","market share","saudi arabia","middle east","equity markets","switzerland","unemployment","jim reid","bls","testimony","copper","volatility","germany","monetary policy","bank of england","trade deficit","payroll data"],
"url":"http://www.newsphiles.org/",
"feeds":[{
"id":70196,
"permalink":"zero hedge",
"name":"Zero Hedge"
}],
"author":"Tyler Durden"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":5,
"facebook_comments":0,
"facebook_total":5,
"twitter":40,
"pinterest":0,
"linkedin":0,
"google_plusones":1
},
"topics":[{
"id":4095,
"name":"markets",
"label":"Markets",
"score":0.12378092855215073
},{
"id":2749,
"name":"fed",
"label":"FED",
"score":0.1127660945057869
},{
"id":319,
"name":"euro",
"label":"Euro",
"score":0.09667244553565979
},{
"id":310,
"name":"greece",
"label":"Greece",
"score":0.09213504195213318
},{
"id":949,
"name":"banking",
"label":"Banking",
"score":0.0886622816324234
},{
"id":10479,
"name":"employment",
"label":"Employment",
"score":0.08462955057621002
},{
"id":11630,
"name":"currencies",
"label":"Currencies",
"score":0.07628319412469864
},{
"id":1405,
"name":"eurozone",
"label":"Eurozone",
"score":0.07593530416488647
},{
"id":13723,
"name":"financial markets",
"label":"Financial Markets",
"score":0.07269618660211563
},{
"id":9046,
"name":"financial sector",
"label":"Financial Sector",
"score":0.06842157989740372
}],
"videos":[]
}],
"clusterId":147225112,
"clusterSize":1,
"score":0.05483352765440941
},{
"articles":[{
"id":146926374,
"created_at":"2015-02-04 23:33:28",
"type":"articles",
"title":"Pfizer breast cancer drug gets early FDA approval",
"language_code":"en",
"url":"http://www.rdmag.com/news/2015/02/pfizer-breast-cancer-drug-gets-early-fda-approval",
"published_at":"2015-02-04 23:33:28",
"directories":["Ciência"],
"publishings":[{
"id":15260,
"permalink":"reddit-science",
"name":"Reddit Science",
"published_at":"2015-02-04 23:33:28",
"thumbnail":"99678d5003920ee97f51.png",
"categories":[],
"url":"http://www.reddit.com/r/science/",
"feeds":[{
"id":55296,
"permalink":"",
"name":""
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":1,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":2,
"twitter":2,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":58550,
"name":"approval",
"label":"Approval",
"score":0.23342497646808624
},{
"id":2731,
"name":"breast cancer",
"label":"Breast Cancer",
"score":0.1683599054813385
},{
"id":8634,
"name":"patients",
"label":"Patients",
"score":0.16541148722171783
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.15242619812488556
},{
"id":14962,
"name":"pharmaceutical industry",
"label":"Pharmaceutical Industry",
"score":0.15158036351203918
},{
"id":54777,
"name":"pharmaceutical",
"label":"Pharmaceutical",
"score":0.14172562956809998
},{
"id":8628,
"name":"treatment",
"label":"Treatment",
"score":0.13384057581424713
},{
"id":4767,
"name":"breasts",
"label":"Breasts",
"score":0.1191708967089653
},{
"id":14775,
"name":"cells",
"label":"Cells",
"score":0.11554919183254242
},{
"id":2285,
"name":"medical",
"label":"Medical",
"score":0.10939224809408188
}],
"videos":[]
}],
"clusterId":146705600,
"clusterSize":57,
"score":0.05414874851703644
},{
"articles":[{
"id":147232645,
"created_at":"2015-02-06 13:04:24",
"type":"articles",
"title":"U.S. Index Futures Little Changed Before Payrolls; Twitter Gains",
"language_code":"en",
"url":"http://www.bloomberg.com/news/articles/2015-02-06/u-s-index-futures-little-changed-before-payrolls-twitter-gains",
"published_at":"2015-02-06 10:56:00",
"directories":[null],
"publishings":[{
"id":15203,
"permalink":"bloomberg-markets",
"name":"Bloomberg Markets",
"published_at":"2015-02-06 10:56:00",
"thumbnail":"0f818bb3c3e67b890472.png",
"categories":[],
"url":"http://www.bloomberg.com/markets-magazine/",
"feeds":[{
"id":65337,
"permalink":null,
"name":null
}]
}],
"images":[{
"url":"b22fd69951f1f21c3c0456cfac356190.jpg",
"width":2200,
"height":1564
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":1,
"twitter":4,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":31595,
"name":"jobless rate",
"label":"Jobless Rate",
"score":0.10093377530574799
},{
"id":5097,
"name":"dow jones industrial average",
"label":"Dow Jones Industrial Average",
"score":0.08874040096998215
},{
"id":5089,
"name":"dow jones",
"label":"Dow Jones",
"score":0.08503179252147675
},{
"id":33804,
"name":"labor department",
"label":"Labor Department",
"score":0.07296546548604965
},{
"id":25433,
"name":"u.s. economy",
"label":"U.S. Economy",
"score":0.07041270285844803
},{
"id":13675,
"name":"interest rates",
"label":"Interest Rates",
"score":0.06506659090518951
},{
"id":10212,
"name":"profit",
"label":"Profit",
"score":0.06492287665605545
},{
"id":26652,
"name":"rate",
"label":"Rate",
"score":0.06423301249742508
},{
"id":9273,
"name":"revenue",
"label":"Revenue",
"score":0.05761570483446121
},{
"id":27407,
"name":"equities",
"label":"Equities",
"score":0.05311841145157814
}],
"videos":[]
}],
"clusterId":147231585,
"clusterSize":12,
"score":0.05198049172759056
},{
"articles":[{
"id":146897310,
"created_at":"2015-02-04 20:31:13",
"type":"articles",
"title":"Pfizer Reports FDA Acceptance For Review Of SNDA For Oral Xelja",
"language_code":"en",
"url":"http://www.benzinga.com/news/15/02/5211295/pfizer-reports-fda-acceptance-for-review-of-snda-for-oral-xelja",
"published_at":"2015-02-04 20:23:03",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-04 20:23:03",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["benzinga","press releases","news","pfe","us7170811035"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49642,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
},{
"id":49645,
"permalink":"press releases",
"name":"Press Releases"
},{
"id":49674,
"permalink":"news",
"name":"News"
},{
"id":49712,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
}],
"author":"Paul Quintaro"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.4479469954967499
},{
"id":8626,
"name":"arthritis",
"label":"Arthritis",
"score":0.24095560610294342
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.20932863652706146
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.16491641104221344
},{
"id":23275,
"name":"abt",
"label":"ABT",
"score":0.07526581734418869
},{
"id":26602,
"name":"prescription drugs",
"label":"Prescription Drugs",
"score":0.07413144409656525
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.07293979078531265
},{
"id":8628,
"name":"treatment",
"label":"Treatment",
"score":0.0708780363202095
},{
"id":3889,
"name":"azn",
"label":"AZN",
"score":0.06554191559553146
},{
"id":908,
"name":"jnj",
"label":"JNJ",
"score":0.06454629451036453
}],
"videos":[]
}],
"clusterId":146897310,
"clusterSize":1,
"score":0.04909077286720276
},{
"articles":[{
"id":146899777,
"created_at":"2015-02-04 20:44:09",
"type":"articles",
"title":"Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis",
"language_code":"en",
"url":"http://www.benzinga.com/pressreleases/15/02/b5211294/pfizer-announces-fda-acceptance-for-review-of-supplemental-new-drug-app",
"published_at":"2015-02-04 20:22:28",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-04 20:22:28",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["pfe","benzinga","press releases","us7170811035"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49645,
"permalink":"press releases",
"name":"Press Releases"
}],
"author":"Business Wire"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.3304676115512848
},{
"id":8626,
"name":"arthritis",
"label":"Arthritis",
"score":0.30445241928100586
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.16078931093215942
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.14131835103034973
},{
"id":5272,
"name":"supplements",
"label":"Supplements",
"score":0.09071757644414902
},{
"id":8634,
"name":"patients",
"label":"Patients",
"score":0.09034687280654907
},{
"id":8628,
"name":"treatment",
"label":"Treatment",
"score":0.08601419627666473
},{
"id":23275,
"name":"abt",
"label":"ABT",
"score":0.07973034679889679
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.07432690262794495
},{
"id":3889,
"name":"azn",
"label":"AZN",
"score":0.07007768005132675
}],
"videos":[]
}],
"clusterId":146899777,
"clusterSize":2,
"score":0.0490766204893589
},{
"articles":[{
"id":146888483,
"created_at":"2015-02-04 19:40:07",
"type":"articles",
"title":"Pfizer Just Won With This Breast Cancer Drug",
"language_code":"en",
"url":"http://www.benzinga.com/trading-ideas/long-ideas/15/02/5210897/pfizer-just-won-with-this-breast-cancer-drug",
"published_at":"2015-02-04 19:37:34",
"directories":["Negócios"],
"publishings":[{
"id":13872,
"permalink":"benzinga",
"name":"Benzinga",
"published_at":"2015-02-04 19:37:34",
"thumbnail":"2aab6cfbdedfcb44537a.png",
"categories":["us66987v1098","benzinga","nvs","fda","ipxl","pfe","us45256b1017","us0184901025","long ideas","agn","us7170811035","trading ideas"],
"url":"http://www.benzinga.com",
"feeds":[{
"id":49642,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
},{
"id":49643,
"permalink":"fda",
"name":"FDA"
},{
"id":49690,
"permalink":"trading ideas",
"name":"Trading Ideas"
},{
"id":49711,
"permalink":"long ideas",
"name":"Long Ideas"
},{
"id":49712,
"permalink":"benzinga stock market quotes business news financial news trading ideas and stock research by professionals",
"name":"Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals"
}],
"author":"Zacks"
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.30562812089920044
},{
"id":2731,
"name":"breast cancer",
"label":"Breast Cancer",
"score":0.2711911201477051
},{
"id":17357,
"name":"agn",
"label":"AGN",
"score":0.21600890159606934
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.2099081575870514
},{
"id":5817,
"name":"novartis",
"label":"Novartis",
"score":0.12956257164478302
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.10362189263105392
},{
"id":120,
"name":"drugs",
"label":"Drugs",
"score":0.08134717494249344
},{
"id":40184,
"name":"aveo",
"label":"Aveo",
"score":0.08060326427221298
},{
"id":29462,
"name":"teva",
"label":"Teva",
"score":0.07779935747385025
},{
"id":1522,
"name":"nyse t",
"label":"Nyse T",
"score":0.07269643247127533
}],
"videos":[]
}],
"clusterId":146701480,
"clusterSize":20,
"score":0.04800894111394882
},{
"articles":[{
"id":147217367,
"created_at":"2015-02-06 11:33:28",
"type":"articles",
"title":"How US Companies Stash Billions Overseas\u2014Tax-Free",
"language_code":"en",
"url":"http://www.motherjones.com/politics/2015/02/foreign-overseas-tax-inversion-evasion-obama",
"published_at":"2015-02-06 11:00:09",
"directories":["Sustentabilidade","Política"],
"publishings":[{
"id":2915,
"permalink":"mother-jones",
"name":"Mother Jones",
"published_at":"2015-02-06 11:00:09",
"thumbnail":"444179c1d8a843ed1e63.png",
"categories":["international","money in politics","corporations","charts","top stories","politics","regulatory affairs","economy"],
"url":"http://motherjones.com/",
"feeds":[{
"id":48873,
"permalink":"mojo blogs and articles mother jones",
"name":"MoJo Blogs and Articles \\| Mother Jones"
},{
"id":48875,
"permalink":"mojo articles mother jones",
"name":"MoJo Articles \\| Mother Jones"
},{
"id":48876,
"permalink":"politics mother jones",
"name":"Politics \\| Mother Jones"
}],
"author":"Erika Eichelberger and Dave Gilson"
},{
"id":15265,
"permalink":"reddit-politics",
"name":"Reddit Politics",
"published_at":"2015-02-06 13:02:27",
"thumbnail":"9fe2b4a70acb38841134.png",
"categories":[],
"url":"http://www.reddit.com/r/politics/",
"feeds":[{
"id":55301,
"permalink":"",
"name":""
}]
}],
"images":[{
"url":"f682d240106e8a2a87596c26912efe95.jpg",
"width":630,
"height":447
}],
"social_metrics":{
"facebook_likes":4,
"facebook_shares":11,
"facebook_comments":0,
"facebook_total":15,
"twitter":69,
"pinterest":0,
"linkedin":4,
"google_plusones":0
},
"topics":[{
"id":9746,
"name":"taxes",
"label":"Taxes",
"score":0.18505330383777618
},{
"id":10212,
"name":"profit",
"label":"Profit",
"score":0.13152393698692322
},{
"id":17986,
"name":"corporate taxes",
"label":"Corporate Taxes",
"score":0.1295107752084732
},{
"id":26202,
"name":"corporations",
"label":"Corporations",
"score":0.09536322206258774
},{
"id":9273,
"name":"revenue",
"label":"Revenue",
"score":0.09426096826791763
},{
"id":24192,
"name":"profits",
"label":"Profits",
"score":0.08783385157585144
},{
"id":17454,
"name":"company",
"label":"Company",
"score":0.07758093625307083
},{
"id":40297,
"name":"capital gains tax",
"label":"Capital Gains Tax",
"score":0.06744221597909927
},{
"id":30364,
"name":"exxon mobil",
"label":"Exxon Mobil",
"score":0.05847044289112091
},{
"id":29274,
"name":"capitalism",
"label":"Capitalism",
"score":0.05776973068714142
}],
"videos":[{
"url":"http://youtube.com/watch?v=noWm5XvdTug",
"thumb_filename":"bd55c6a96a2ab4e3dbbf21301b6a1712.jpg",
"thumb_width":320,
"thumb_height":180
}]
}],
"clusterId":147217367,
"clusterSize":1,
"score":0.04456791281700134
},{
"articles":[{
"id":146834434,
"created_at":"2015-02-04 15:09:55",
"type":"articles",
"title":"Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board",
"language_code":"en",
"url":"http://www.forbes.com/sites/antoinegara/2015/02/04/pfizer-spinoff-zoetis-takes-pershing-squares-doyle-onto-board/",
"published_at":"2015-02-04 15:03:00",
"directories":["Negócios","Economia"],
"publishings":[{
"id":10972,
"permalink":"forbes",
"name":"Forbes",
"published_at":"2015-02-04 15:03:00",
"thumbnail":"ts16aOJP0G2xq8inmYQ3rAWxV6PgJuIETAOEk9yX.png",
"categories":["nyse:zts","nyse:agn","nyse:vrx","nyse:pfe"],
"url":"http://www.forbes.com/",
"feeds":[{
"id":24310,
"permalink":"forbes",
"name":"Forbes"
},{
"id":31826,
"permalink":"information for the worlds business leaders forbescom rss",
"name":"Information for the World's Business Leaders - Forbes.com - RSS"
}],
"author":"Antoine Gara, Forbes Staff"
}],
"images":[{
"url":"0f3a977f8ac43123aadbe1f13407be78.jpg",
"width":1940,
"height":1089
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":11,
"facebook_comments":0,
"facebook_total":11,
"twitter":137,
"pinterest":0,
"linkedin":17,
"google_plusones":0
},
"topics":[{
"id":22671,
"name":"hedge fund",
"label":"Hedge Fund",
"score":0.11181269586086273
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.10893139988183975
},{
"id":28424,
"name":"pharmaceuticals",
"label":"Pharmaceuticals",
"score":0.10402119159698486
},{
"id":16490,
"name":"hedge funds",
"label":"Hedge Funds",
"score":0.09978983551263809
},{
"id":44225,
"name":"herbalife",
"label":"Herbalife",
"score":0.07092271745204926
},{
"id":2255,
"name":"botox",
"label":"Botox",
"score":0.07058684527873993
},{
"id":8988,
"name":"ggp",
"label":"GGP",
"score":0.06936890631914139
},{
"id":17357,
"name":"agn",
"label":"AGN",
"score":0.06408028304576874
},{
"id":32353,
"name":"act",
"label":"ACT",
"score":0.06397826969623566
},{
"id":39344,
"name":"cp",
"label":"CP",
"score":0.06343282759189606
}],
"videos":[]
}],
"clusterId":146819198,
"clusterSize":2,
"score":0.04230983555316925
},{
"articles":[{
"id":146827487,
"created_at":"2015-02-04 14:28:04",
"type":"articles",
"title":"Pharmalot, Pharmalittle: We\u2019re Reading About Gilead, Pfizer and Much More!!",
"language_code":"en",
"url":"http://blogs.wsj.com/pharmalot/2015/02/04/pharmalot-pharmalittle-were-reading-about-gilead-pfizer-and-much-more/?mod=WSJBlog",
"published_at":"2015-02-04 13:52:44",
"directories":[null],
"publishings":[{
"id":8625,
"permalink":"pharmalot",
"name":"Pharmalot",
"published_at":"2015-02-04 13:52:44",
"thumbnail":null,
"categories":["lymphoma","u.s. trade representative","gilead sciences","deals","biotechs","harvoni","mergers & acquisitions","regulatory","mannkind","afrezza","breast cancer","pricing & patient access","biologics","food and drug administration","fda","hepatitis c","intellectual property","amgen","sovaldi","generics","câncer","prescription drug costs","insomnia","generic drug makers","uncategorized","pfizer","biosimilar","diabetes","merck","michael froman","abbvie","sanofi","sleeping pills","eli lilly","patents","valeant pharmaceuticals","roche"],
"url":"http://www.pharmalot.com/",
"feeds":[{
"id":81103,
"permalink":"pharmalot",
"name":"Pharmalot"
}],
"author":"Ed Silverman"
}],
"images":[{
"url":"1f21c397dc42264745204b7627b69427.jpg",
"width":262,
"height":174
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":2,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.30129319429397583
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.2381121963262558
},{
"id":16655,
"name":"roche",
"label":"Roche",
"score":0.22165988385677338
},{
"id":36802,
"name":"amgen",
"label":"Amgen",
"score":0.21260663866996765
},{
"id":1933,
"name":"merck",
"label":"Merck",
"score":0.20409797132015228
},{
"id":17439,
"name":"hepatitis c",
"label":"Hepatitis C",
"score":0.20312295854091644
},{
"id":10845,
"name":"eli lilly",
"label":"Eli Lilly",
"score":0.18371784687042236
},{
"id":14964,
"name":"pharma",
"label":"Pharma",
"score":0.16060763597488403
},{
"id":517,
"name":"sanofi",
"label":"Sanofi",
"score":0.14107206463813782
},{
"id":46324,
"name":"abbv",
"label":"Abbv",
"score":0.13703061640262604
}],
"videos":[]
}],
"clusterId":146827487,
"clusterSize":1,
"score":0.04104697331786156
},{
"articles":[{
"id":146825406,
"created_at":"2015-02-04 14:16:37",
"type":"articles",
"title":"$4 Billion Opportunity: Pfizer inc. Snags Approval for Potential Blockbuster",
"language_code":"en",
"url":"http://www.foxbusiness.com/investing/2015/02/04/4-billion-opportunity-pfizer-inc-snags-approval-for-potential-blockbuster/",
"published_at":"2015-02-04 13:27:26",
"directories":["Economia"],
"publishings":[{
"id":10763,
"permalink":"fox-business",
"name":"FOX Business",
"published_at":"2015-02-04 13:27:26",
"thumbnail":"b5678fef0ea3dfffbd6d.png",
"categories":[],
"url":"http://www.foxbusiness.com/",
"feeds":[{
"id":36056,
"permalink":"",
"name":"FOX business investing"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":5,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.3273527920246124
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.10772956162691116
},{
"id":1794,
"name":"cancer",
"label":"Cancer",
"score":0.10735911875963211
},{
"id":2731,
"name":"breast cancer",
"label":"Breast Cancer",
"score":0.10527629405260086
},{
"id":58550,
"name":"approval",
"label":"Approval",
"score":0.09732015430927277
},{
"id":120,
"name":"drugs",
"label":"Drugs",
"score":0.09627675265073776
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.09572439640760422
},{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.09352190792560577
},{
"id":4781,
"name":"chemotherapy",
"label":"Chemotherapy",
"score":0.08825419843196869
},{
"id":31995,
"name":"gale",
"label":"Gale",
"score":0.08410170674324036
}],
"videos":[]
}],
"clusterId":146818545,
"clusterSize":2,
"score":0.04060909524559975
},{
"articles":[{
"id":146848284,
"created_at":"2015-02-04 16:17:13",
"type":"articles",
"title":"Pfizer Marks World Cancer Day with Grant to Union for International Cancer Control to Address the Needs of Metastatic Breast",
"language_code":"en",
"url":"http://www.bloomberg.com/article/2015-02-04/aEK4IcDYju1Q.html",
"published_at":"2015-02-04 13:00:00",
"directories":[null],
"publishings":[{
"id":15203,
"permalink":"bloomberg-markets",
"name":"Bloomberg Markets",
"published_at":"2015-02-04 13:00:00",
"thumbnail":"0f818bb3c3e67b890472.png",
"categories":[],
"url":"http://www.bloomberg.com/markets-magazine/",
"feeds":[{
"id":65337,
"permalink":null,
"name":null
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":1794,
"name":"cancer",
"label":"Cancer",
"score":0.15278004109859467
},{
"id":2731,
"name":"breast cancer",
"label":"Breast Cancer",
"score":0.12626758217811584
},{
"id":104,
"name":"oncology",
"label":"Oncology",
"score":0.11084260791540146
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.10513191670179367
},{
"id":8634,
"name":"patients",
"label":"Patients",
"score":0.10310781747102737
},{
"id":4781,
"name":"chemotherapy",
"label":"Chemotherapy",
"score":0.07910683751106262
},{
"id":19920,
"name":"cancer research",
"label":"Cancer Research",
"score":0.07849318534135818
},{
"id":4767,
"name":"breasts",
"label":"Breasts",
"score":0.0678589716553688
},{
"id":18671,
"name":"mbc",
"label":"MBC",
"score":0.0603397898375988
},{
"id":42941,
"name":"grants",
"label":"Grants",
"score":0.05631712079048157
}],
"videos":[]
}],
"clusterId":146848284,
"clusterSize":1,
"score":0.040143899619579315
},{
"articles":[{
"id":146812244,
"created_at":"2015-02-04 13:05:03",
"type":"articles",
"title":"Disney, Macy's in focus; Pfizer Gets Early Approval for Drug",
"language_code":"en",
"url":"http://www.thestreet.com/video/13034026/disney-macys-in-focus-pfizer-gets-early-approval-for-drug.html",
"published_at":"2015-02-04 12:41:00",
"directories":["Negócios"],
"publishings":[{
"id":13873,
"permalink":"the-street",
"name":"The Street",
"published_at":"2015-02-04 12:41:00",
"thumbnail":"ff606b418a658420f68c.png",
"categories":[],
"url":"http://www.thestreet.com",
"feeds":[{
"id":49727,
"permalink":"latest videos",
"name":"Latest Videos"
},{
"id":49738,
"permalink":"latest videos",
"name":"Latest Videos"
}]
}],
"images":[{
"url":"497f103cde1b9b8ae442e5728691b233.jpg",
"width":1120,
"height":630
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":1,
"facebook_comments":0,
"facebook_total":1,
"twitter":1,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.18371662497520447
},{
"id":20412,
"name":"pharmacy",
"label":"Pharmacy",
"score":0.13677693903446198
},{
"id":13989,
"name":"coffee",
"label":"Coffee",
"score":0.08493697643280029
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.07753626257181168
},{
"id":58550,
"name":"approval",
"label":"Approval",
"score":0.07330714166164398
},{
"id":26602,
"name":"prescription drugs",
"label":"Prescription Drugs",
"score":0.062425777316093445
},{
"id":120,
"name":"drugs",
"label":"Drugs",
"score":0.060777533799409866
},{
"id":5594,
"name":"soda",
"label":"Soda",
"score":0.05729397386312485
},{
"id":8579,
"name":"alzheimer",
"label":"Alzheimer",
"score":0.05431501567363739
},{
"id":14962,
"name":"pharmaceutical industry",
"label":"Pharmaceutical Industry",
"score":0.05312877520918846
}],
"videos":[]
}],
"clusterId":146812244,
"clusterSize":1,
"score":0.039827413856983185
},{
"articles":[{
"id":147206881,
"created_at":"2015-02-06 10:17:09",
"type":"articles",
"title":"CambridgeNews published Revenue grows at AstraZeneca as firm acquires rights to Actavis...",
"language_code":"en",
"url":"http://www.cambridge-news.co.uk/Revenue-grows-AstraZeneca-firm-acquires-rights/story-25985525-detail/story.html",
"published_at":"2015-02-06 10:06:50",
"directories":["Cotidiano"],
"publishings":[{
"id":16372,
"permalink":"cambridge-news",
"name":"Cambridge News",
"published_at":"2015-02-06 10:06:50",
"thumbnail":"d89bcb922e6d40adcfdd.png",
"categories":[],
"url":"http://www.cambridge-news.co.uk/Home/",
"feeds":[{
"id":69632,
"permalink":"cambridge news home",
"name":"Cambridge News - Home"
},{
"id":69633,
"permalink":"cambridge news news",
"name":"Cambridge News - News"
}],
"author":"CambridgeNews"
}],
"images":[{
"url":"1fbaab15e5147ffbcc2321e65462a4eb.jpg",
"width":618,
"height":416
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":30231,
"name":"astrazeneca",
"label":"Astrazeneca",
"score":0.35297060012817383
},{
"id":9273,
"name":"revenue",
"label":"Revenue",
"score":0.08429115265607834
},{
"id":32353,
"name":"act",
"label":"ACT",
"score":0.06580057740211487
},{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.06541623175144196
},{
"id":3889,
"name":"azn",
"label":"AZN",
"score":0.0649295374751091
}],
"videos":[]
}],
"clusterId":147206881,
"clusterSize":1,
"score":0.03525729104876518
},{
"articles":[{
"id":147051101,
"created_at":"2015-02-05 14:50:14",
"type":"articles",
"title":"Pfizer Research Prize 2015 for Valérie D'Acremont",
"language_code":"en",
"url":"http://www.eurekalert.org/pub_releases/2015-02/stap-prp020415.php",
"published_at":"2015-02-04 05:00:00",
"directories":["Ciência"],
"publishings":[{
"id":10178,
"permalink":"eurekalert",
"name":"EurekAlert!",
"published_at":"2015-02-04 05:00:00",
"thumbnail":"9saZQeD7ZacQBh1R08WwbHcDnXrLjErnoKVrVi4f.png",
"categories":[],
"url":"http://www.eurekalert.org/",
"feeds":[{
"id":32801,
"permalink":"eurekalert chemistry physics and materials sciences",
"name":"EurekAlert! - Chemistry, Physics and Materials Sciences"
},{
"id":32804,
"permalink":"eurekalert infectious and emerging diseases",
"name":"EurekAlert! - Infectious and Emerging Diseases"
},{
"id":32806,
"permalink":"eurekalert medicine and health",
"name":"EurekAlert! - Medicine and Health"
},{
"id":32809,
"permalink":"eurekalert policy and ethics",
"name":"EurekAlert! - Policy and Ethics"
}]
}],
"images":[{
"url":"a36c31e71cc89983d813085753284d96.jpg",
"width":720,
"height":960
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":4,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":11482,
"name":"antibiotics",
"label":"Antibiotics",
"score":0.13884080946445465
},{
"id":21078,
"name":"malaria",
"label":"Malaria",
"score":0.13252924382686615
},{
"id":16830,
"name":"infections",
"label":"Infections",
"score":0.12220200151205063
},{
"id":31430,
"name":"resistance",
"label":"Resistance",
"score":0.08998165279626846
},{
"id":26433,
"name":"drug resistance",
"label":"Drug Resistance",
"score":0.0884823352098465
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.08054939657449722
},{
"id":2998,
"name":"illness",
"label":"Illness",
"score":0.06572000682353973
},{
"id":14541,
"name":"public health",
"label":"Public Health",
"score":0.06302140653133392
},{
"id":35545,
"name":"parasite",
"label":"Parasite",
"score":0.060622528195381165
},{
"id":1272,
"name":"med",
"label":"MED",
"score":0.0552312396466732
}],
"videos":[]
}],
"clusterId":147051101,
"clusterSize":1,
"score":0.03334978595376015
},{
"articles":[{
"id":146726008,
"created_at":"2015-02-03 23:53:19",
"type":"articles",
"title":"Pfizer gets FDA approval for breast cancer drug Inbrance",
"language_code":"en",
"url":"http://www.marketwatch.com/story/pfizer-gets-fda-approval-for-breast-cancer-drug-inbrance-2015-02-03?siteid=rss",
"published_at":"2015-02-03 23:39:23",
"directories":["Negócios"],
"publishings":[{
"id":11151,
"permalink":"market-watch-wsj",
"name":"Market Watch WSJ",
"published_at":"2015-02-03 23:39:23",
"thumbnail":"1377cdaef091b2f972c1.png",
"categories":[],
"url":"http://www.marketwatch.com/",
"feeds":[{
"id":58752,
"permalink":"marketwatchcom marketpulse",
"name":"MarketWatch.com - MarketPulse"
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":8,
"facebook_shares":9,
"facebook_comments":0,
"facebook_total":17,
"twitter":7,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.17373023927211761
},{
"id":20412,
"name":"pharmacy",
"label":"Pharmacy",
"score":0.1599927395582199
},{
"id":2731,
"name":"breast cancer",
"label":"Breast Cancer",
"score":0.10383650660514832
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.08008147031068802
},{
"id":58550,
"name":"approval",
"label":"Approval",
"score":0.07506608217954636
},{
"id":26602,
"name":"prescription drugs",
"label":"Prescription Drugs",
"score":0.06861366331577301
},{
"id":4891,
"name":"menopause",
"label":"Menopause",
"score":0.06826583296060562
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.06582187116146088
},{
"id":120,
"name":"drugs",
"label":"Drugs",
"score":0.061896730214357376
},{
"id":14962,
"name":"pharmaceutical industry",
"label":"Pharmaceutical Industry",
"score":0.061793334782123566
}],
"videos":[]
}],
"clusterId":146726008,
"clusterSize":2,
"score":0.029891449958086014
},{
"articles":[{
"id":146718916,
"created_at":"2015-02-03 23:03:15",
"type":"articles",
"title":"Pfizer Inc (PFE) Earns FDA Approval For Breast Cancer Drug",
"language_code":"en",
"url":"http://www.ibtimes.com/pfizer-inc-pfe-earns-fda-approval-breast-cancer-drug-1804486",
"published_at":"2015-02-03 23:02:04",
"directories":["Negócios"],
"publishings":[{
"id":9288,
"permalink":"ibtimes",
"name":"IBTimes International Business Times",
"published_at":"2015-02-03 23:02:04",
"thumbnail":"vPIhRCdtFXLgAATireJmHfVvqdGQdHckwJmZNW9E.png",
"categories":[],
"url":"http://www.ibtimes.com/",
"feeds":[{
"id":26115,
"permalink":"ibtimes-com-economy",
"name":"IBTimes Economy"
},{
"id":27147,
"permalink":"ibtimes-us",
"name":"IBTimes US"
},{
"id":27148,
"permalink":"ibtimes-companies",
"name":"IBTimes Companies"
},{
"id":27149,
"permalink":"ibtimes-tech",
"name":"IBTimes Tech"
},{
"id":27153,
"permalink":"ibtimes-art-design",
"name":"IBTimes Art & Design"
},{
"id":27154,
"permalink":"ibtimes-luxury-brands",
"name":"IBTimes Luxury & Brands"
},{
"id":27157,
"permalink":"ibtimes-business-health",
"name":"IBTimes Business & Health"
},{
"id":27159,
"permalink":"ibtimes-books",
"name":"IBTimes Books"
},{
"id":27161,
"permalink":"ibtimes-tech-trends",
"name":"IBTimes Tech & Trends"
},{
"id":27163,
"permalink":"ibtimes-markets-forex",
"name":"IBTimes Markets Forex"
},{
"id":27164,
"permalink":"ibtimes-real-estate",
"name":"IBTimes Real Estate"
},{
"id":32065,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32073,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32074,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32075,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32076,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32077,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32078,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32079,
"permalink":"international business times",
"name":"International Business Times"
},{
"id":32080,
"permalink":"international business times",
"name":"International Business Times"
}],
"author":"Amy Nordrum"
}],
"images":[{
"url":"1011dd85a3e95c4a55007e6407c80578.jpg",
"width":770,
"height":513
}],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":3,
"facebook_comments":0,
"facebook_total":3,
"twitter":4,
"pinterest":0,
"linkedin":2,
"google_plusones":0
},
"topics":[{
"id":14965,
"name":"pfizer",
"label":"Pfizer",
"score":0.3099609315395355
},{
"id":5766,
"name":"pfe",
"label":"PFE",
"score":0.1289634108543396
},{
"id":58550,
"name":"approval",
"label":"Approval",
"score":0.12062153965234756
},{
"id":8628,
"name":"treatment",
"label":"Treatment",
"score":0.10691025108098984
},{
"id":18176,
"name":"fda",
"label":"FDA",
"score":0.09587977081537247
},{
"id":8579,
"name":"alzheimer",
"label":"Alzheimer",
"score":0.09080473333597183
},{
"id":8634,
"name":"patients",
"label":"Patients",
"score":0.0790017694234848
},{
"id":26482,
"name":"viagra",
"label":"Viagra",
"score":0.07771432399749756
},{
"id":66733,
"name":"who",
"label":"WHO",
"score":0.07704629004001617
},{
"id":10877,
"name":"bayer",
"label":"Bayer",
"score":0.07637768983840942
}],
"videos":[]
}],
"clusterId":146718916,
"clusterSize":1,
"score":0.029531652107834816
},{
"articles":[{
"id":147219853,
"created_at":"2015-02-06 11:46:42",
"type":"articles",
"title":"India Morning Call-Global Markets",
"language_code":"en",
"url":"http://in.reuters.com/article/2015/02/06/morningcall-india-idINL4N0VF4I720150206?type=companyNews",
"published_at":"2015-02-06 08:26:00",
"directories":[null],
"publishings":[{
"id":16927,
"permalink":"reuters-india",
"name":"Reuters India",
"published_at":"2015-02-06 08:26:00",
"thumbnail":"e15a0363bdce9a3c5994.png",
"categories":[],
"url":"http://in.reuters.com",
"feeds":[{
"id":85878,
"permalink":null,
"name":null
}]
}],
"images":[],
"social_metrics":{
"facebook_likes":0,
"facebook_shares":0,
"facebook_comments":0,
"facebook_total":0,
"twitter":0,
"pinterest":0,
"linkedin":0,
"google_plusones":0
},
"topics":[{
"id":4095,
"name":"markets",
"label":"Markets",
"score":0.19752168655395508
},{
"id":20220,
"name":"oil prices",
"label":"Oil Prices",
"score":0.14871898293495178
},{
"id":18504,
"name":"prices",
"label":"Prices",
"score":0.09752611815929413
},{
"id":13723,
"name":"financial markets",
"label":"Financial Markets",
"score":0.09556760638952255
},{
"id":24916,
"name":"wall",
"label":"Wall",
"score":0.08968853950500488
},{
"id":18584,
"name":"yen",
"label":"YEN",
"score":0.08246692270040512
},{
"id":27407,
"name":"equities",
"label":"Equities",
"score":0.08032511174678802
},{
"id":13675,
"name":"interest rates",
"label":"Interest Rates",
"score":0.07404843717813492
},{
"id":61681,
"name":"thursday",
"label":"Thursday",
"score":0.0722031369805336
},{
"id":30730,
"name":"trading",
"label":"Trading",
"score":0.07040106505155563
}],
"videos":[]
}],
"clusterId":147171078,
"clusterSize":3,
"score":0.02358720637857914
}],
"articleIds":[147225112,146897310,147166658,147103389,147061902,147077272,147217367,147225803,147034827,147011785,147106439,147104003,146888483,146827487,147168215,146899777,147234903,146812244,147051062,147219853,147137614,147081946,146825406,147018875,147050645,146926374,147149222,147082157,147231354,146834434,147220761,147062518,146726008,147232645,147051641,147236539,146718916,147206881,147228790,147176078,147013194,147051101,147061583,147007978,147147283,147104066,147234743,147175761,146848284,147239368],
"info":{
"tookInMillis":337,
"apiTookInMillis":346,
"totalHits":"47814",
"isTotalHitsEstimated":false,
"timedOut":false
}
}
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment